|1.||Schwartz, T W: 3 articles (08/2001 - 01/2000)|
|2.||Gerstoft, J: 3 articles (08/2001 - 01/2000)|
|3.||Lüttichau, H R: 3 articles (08/2001 - 01/2000)|
|4.||Yamanishi, Koichi: 1 article (04/2012)|
|5.||Nakano, Kazushi: 1 article (04/2012)|
|6.||Ohsaki, Eriko: 1 article (04/2012)|
|7.||Ueda, Keiji: 1 article (04/2012)|
|8.||Sato, Yuko: 1 article (04/2012)|
|9.||Katano, Harutaka: 1 article (04/2012)|
|10.||Tadagaki, Kenjiro: 1 article (04/2012)|
|1.||Neoplasm Metastasis (Metastasis)
11/01/2004 - "Adhesion and chemotaxis assays were also used to evaluate the effect of vMIP-II on MCF-7 cells in different steps of metastasis. "
11/01/2004 - "This study was to investigate effect of viral macrophage inflammatory protein-II (vMIP-II), an antagonist of CXCR4, on metastasis of breast cancer cell line MCF-7. "
|3.||Breast Neoplasms (Breast Cancer)
|4.||Brain Injuries (Brain Injury)
08/01/2003 - "Cells transfected with SIVmac239Delta3DeltaLTR-vMIP-II vectors expressed biologically active vMIP-II that bound CEMx174 cells and suppressed SIVmac251 infection. "
08/01/2003 - "Regarding its antiviral properties, vMIP-II expressed from bacteria and SIV-based vectors bound the surface of CEMx174 cells and specifically suppressed SIVmac251 infection. "
08/01/2003 - "The effects of HHV-8 vMIP-II on SIVmac251 infection and replication competent and incompetent SIVmac239Delta3 vectors."
05/01/2001 - "The trHIV-1(NL4-3) acquired resistance to vMIP II, which could inhibit both X4 and R5 HIV-1 infection. "
11/01/1999 - "We report the solution structure of the chemotactic cytokine (chemokine) vMIP-II. This protein has unique biological activities in that it blocks infection by several different human immunodeficiency virus type 1 (HIV-1) strains. "
|3.||Proteins (Proteins, Gene)
|7.||Chemokine CCL2 (Monocyte Chemoattractant Protein 1)